We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Clinical Research Data Warehouse Built for Customized Treatment Research

By MedImaging International staff writers
Posted on 25 Jun 2009
A clinical data research warehouse has been built to speed the development of new treatments for diseases such as diabetes, cystic fibrosis, and cancer. IBM (Armonk, NY, USA) reported that it has teamed with University of North Carolina Health Care (UNCHC; Chapel Hill, USA) to accomplish this task. With the storage provided by the Carolina Data Warehouse for Health (CDW-H), medical researchers can analyze vast amounts of patient data uncovering trends in a matter of seconds. This avoids the time-consuming manual analysis of large quantities of patient records and treatment options.

"With the deployment of the Carolina Data Warehouse for Health, we have been able to increase the timeliness of the information available to our researchers, staff, and physicians,” said Donald Spencer, M.D., MBA, associate director of medical informatics, UNC Health Care. "Because the system can also support general queries that relate to the diagnosis and treatment of a wide array of patients, we are now able to make more intelligent decisions leading to improved patient care.”

Built on IBM software and hardware with global services expertise, the CDW-H focuses on diabetes disease management and performance measurement. Dr. Spencer estimates that the warehouse has narrowed the time frame for clinical research significantly. Queries that would previously take weeks now take seconds, he noted. The entire workflow of preparatory research, through regulatory approval, to obtaining a data set will drop from months to weeks.

Currently the project is focused on three major subject areas: in the first--cohort selection--primary users are researchers who need to determine cohort availability for studies, grants, and clinical trial recruitment using "de-identified” (i.e., all personal information removed) data. In the second--diabetes data mart--primary users are clinicians and analysts in the practice area. They utilize the data mart to gain access to information and statistics on diabetics, and prediabetics for disease management, performance reporting, and analysis. In the third—the inpatient data mart--is primarily used by the Quality Improvement Office and hospital analysts to support performance improvement efforts, core measures reporting, and hospital patient population studies/analysis.

"This new data warehouse will allow healthcare professionals to work more intelligently, speeding the development of treatments for disease,” said Dan Pelino, general manager, Global Healthcare and Life Sciences, IBM. "Sharing data on this scale heralds a new era of healthcare, where coordinated, patient-centered care and an adherence to evidence-based medicine can improve the quality of care delivered to people around the world.”

The data warehouse is built on the IBM Health Integration Framework and takes advantage of InfoSphere and WebSphere software, running on System z mainframe and System p computers. UNCHC has now moved the data warehouse into production with secure web portal providing access to anatomized cohort query selection, diabetes and inpatient data marts, business intelligence reports and analytics applications, and supporting clinical translation research.

Related Links:
IBM
University of North Carolina Health Care


Pocket Fetal Doppler
CONTEC10C/CL
Adjustable Mobile Barrier
M-458
Ultrasound Table
Women’s Ultrasound EA Table
Breast Localization System
MAMMOREP LOOP

Channels

Nuclear Medicine

view channel
Image: LHSCRI scientist Dr. Glenn Bauman stands in front of the PET scanner (Photo courtesy of LHSCRI)

New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer

Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.